Capricor Therapeutics
CAPR
CAPR
22 hedge funds and large institutions have $3.84M invested in Capricor Therapeutics in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.52% more ownership
Funds ownership: 0.42% → 0.95% (+0.52%)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.8M | |
| 2 | +$429K | |
| 3 | +$75K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$45K |
| 5 |
Bank of New York Mellon
New York
|
+$44K |
Top Sellers
| 1 | -$190K | |
| 2 | -$142K | |
| 3 | -$78K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$4K |
| 5 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
-$3.54K |